Stimac Davor, Majanovic Sanja Klobucar
Division of Gastroenterology, Department of Internal Medicine, University Hospital Rijeka, Croatia.
Curr Clin Pharmacol. 2013 Aug;8(3):238-46. doi: 10.2174/1574884711308030011.
Obesity is a worldwide health problem associated with substantial morbidity and cost. Lifestyle modification and pharmacotherapy for obesity have limited benefit. Bariatric surgery is effective but with substantial risks, considerable cost and limited patient applicability. Endoscopic approach to obesity has evolved as a result of an attempt to replicate some of the anatomical manipulations and the physiological effects of the traditional weight loss surgery in a minimally invasive manner. Endoscopic interventions performed entirely through the GI tract offer the potential for an ambulatory weight loss procedure that is more cost-effective compared with current surgical approaches. There are two main endoscopic weight loss modalities - restrictive and malabsorptive. Restrictive procedures act to decrease gastric volume by space-occupying prosthesis and/or by suturing or stapling devices that alter gastric anatomy while malabsorptive procedures tend to create malabsorption by preventing food contact with the duodenum and proximal jejunum. Restrictive endoscopic procedures include intragastric balloon treatment, endoluminal vertical gastroplasty, transoral gastroplasty (TOGA) and transoral endoscopic restrictive implant system (TERIS). The duodenojejunal bypass sleeve (DJBS) is a malabsorptive device that mimics such surgical procedure. Gastroduodenojejunal bypass sleeve is a combination of both procedures. Except for intragastric balloon all mentioned procedures are rather novel, tested on a small number of subjects and with limited knowledge on safety and long-term efficacy. Owing to evolving field of evidence-based medicine with demand for rigorous evaluation of the scientific evidence these therapies need to be carefully tested in a randomized controlled manner to determine their safety and efficacy in the short and long-term. This review is aimed to compare endoscopic bariatric interventions with each other and with other weight loss modalities including conventional treatment and surgical procedures.
肥胖是一个全球性的健康问题,与大量的发病率和成本相关。肥胖的生活方式改变和药物治疗益处有限。减肥手术有效,但风险大、成本高且患者适用性有限。由于试图以微创方式复制传统减肥手术的一些解剖操作和生理效应,肥胖的内镜治疗方法得到了发展。完全通过胃肠道进行的内镜干预为门诊减肥手术提供了潜力,与目前的手术方法相比,这种手术更具成本效益。有两种主要的内镜减肥方式——限制性和吸收不良性。限制性手术通过占位假体和/或通过改变胃解剖结构的缝合或吻合器械来减少胃容积,而吸收不良性手术则倾向于通过防止食物与十二指肠和空肠近端接触来造成吸收不良。限制性内镜手术包括胃内球囊治疗、腔内垂直胃成形术、经口胃成形术(TOGA)和经口内镜限制性植入系统(TERIS)。十二指肠空肠旁路套管(DJBS)是一种模仿此类手术的吸收不良性器械。胃十二指肠空肠旁路套管是两种手术的结合。除了胃内球囊外,所有提到的手术都相当新颖,仅在少数受试者身上进行了测试,对安全性和长期疗效的了解有限。由于循证医学领域不断发展,需要对科学证据进行严格评估,因此这些疗法需要以随机对照的方式进行仔细测试,以确定其短期和长期的安全性和疗效。本综述旨在比较内镜减肥干预措施之间以及与其他减肥方式(包括传统治疗和手术程序)的差异。